Best for: Speculative bets on high-frontier tech like gene editing and CRISPR .
Best for: Concentrated exposure to the 25 largest, most liquid biotech stocks . Strategy: Focuses on profitable blue-chip biotechs . Expense Ratio: 0.35% . best biotech etf to buy now
Strategy: Market-cap weighted, dominated by giants like Vertex, Gilead, and Amgen . Expense Ratio: 0.44% . Best for: Low-cost core exposure . Best for: Speculative bets on high-frontier tech like
Strategy: Uses a modified equal-weight index, giving smaller companies more influence . Expense Ratio: 0.35% . Best for: Conservative "buy the basket" exposure . dominated by giants like Vertex
💡 : Use the SEC EDGAR Database to review the latest prospectus and full risk disclosures for these ETFs before investing. If you'd like to narrow this down, tell me:
Your (e.g., long-term stability vs. short-term growth)?